Microbiology Nuts & Bolts
  • Home
  • Basic Concepts
    • What is infection?
    • Normal flora
    • Diagnosing infection
  • Microbiology
    • Basic bacterial identification
    • Interpreting bacteriology results
    • Interpreting serology results
  • Infection Control
    • What is infection control?
    • Universal precautions
    • MRSA
    • Clostridium difficile
  • Clinical Scenarios
    • Respiratory infections
    • Urinary infections
    • GI infections >
      • D&V
      • CDAD
    • CNS infections
    • Skin & bone infections
    • Sepsis
  • Antibiotics
    • Antimicrobial Stewardship
    • How antibiotics work
    • How to choose an antibiotic?
    • Reviewing antibiotics
    • Antibiotic resistance
    • Testing antibiotic resistance
    • Penicillin allergy
    • Theraputic Drug Monitoring
  • Guidelines
  • Lectures & Lecture Notes
    • Medical Students
    • Curriculum for the Foundation Program
    • Foundation Year 1
    • Foundation Year 2
    • Other Lectures
  • The Bug Blog
  • Buy the book...
  • NEW Edition Updates
  • Peer Reviews
  • Want to know more?
  • Contact

Clostridium difficile, il n'est pas difficile!

8/7/2014

 
Clostridium difficile Associated Disease (CDAD) is a bacterial infection caused by Clostridium difficile. In order to acquire it the person has to ingest it, but where they ingest it from is not yet known. The more places scientists look for it, the more they find it, including in retail foods, animals, plants and various water sources. Antibiotics predispose to infection by eliminating the normal flora of the gastrointestinal tract and leaving an ecological niche for the C. difficile bacterium to exploit. The bacterium then produces a toxin which causes a colitis ranging from mild diarrhoea up to pseudomembranous colitis, toxic megacolon and even death. 

The most commonly implicated antibiotics are known as the “4Cs” and include:
• Cephalosporins
• Ciprofloxacin (and the other quinolones)
• Clindamycin
• Co-amoxiclav
Antibiotics only predispose to CDAD
Click for larger image
Up to 3% of the population are asymptomatic carriers of C. difficile and although they do not have symptoms they represent a potential infection control risk, as they can
spread the infection to others.
 
The epidemiology of CDAD has changed a lot over the last 5 years or so. When I first started in microbiology in 2001 CDAD was a hospital problem which was on the increase. The driving force behind it was the over reliance on the cephalosporins: pneumonia was treated with Cefuroxime and Clarithromycin, abdominal infections got Cefuroxime and Metronidazole or “Cef & Met” and pyelonephritis was treated with Cefuroxime and Gentamicin. As a result hospitals with a high incidence of CDAD were advised to switch to using quinolones as these were deemed safe. But it wasn’t long before the honeymoon was over and the 027 strain of C. difficile came into the UK from Canada. Quinolones, ironically, then became the main driver of CDAD.

A lot of effort has been made to control the national “epidemic” of CDAD and since 2008 the number of cases per year of CDAD in the UK have reduce from 55,000 to 15,000. More interestingly, there has also been a shift in where the majority of these cases are occurring; in 2008 60% were in hospital but in 2013 60% were in primary care and whilst the overall numbers have reduced, locally we are seeing the number of community cases increasing! My gut feeling (gut...diarrhoea…ha ha) is that we will see an increase in community cases and that the management of these patients will remain with the primary care physician.

So do you know how this problem should be managed in primary care?
 
Assessment
It is important to make a quick diagnosis of CDAD in patients with diarrhoea so they can be treated as soon as possible.

1.  CDAD should be considered in any patient with diarrhoea
who:
• Is over the age of 65 years
• OR has received antibiotics within the preceding month
• OR has been a hospital inpatient within the preceding month

Patients with diarrhoea without these risk factors do not need to be tested for CDAD.

2.  Send a stool specimen and form stating relevant risk factors (see point 1) to the microbiology laboratory and request C. difficile toxin testing. All UK microbiology laboratories should be able to turn this test around within 24 hours of receiving the sample, even at weekends

3.  Any patient with diarrhoea from any cause should be given advice about toilet hygiene and hand washing. It doesn’t matter what the cause of the diarrhoea is, any bacteria in the gut can be transmitted in faeces

If the result is positive, or the diagnosis is strongly suspected before the result is available, the next step is to assess the severity of the infection: can the patient be managed in the community or do they need admitting to a hospital, and what antibiotics should be used to treat the CDAD?

Risk factors for severe infection include:
• Age > 85 years
• Temperature > 38.5oC
• Immunosuppressed
• Severe abdominal pain or distension

If blood or radiological investigations available severe infection also includes:
• Rising creatinine
• White blood cell count >15 x 109/L OR < 1.5 x 109/L
• Colonic dilatation on abdominal X-ray

Any patient with risk factors for severe infection should be
referred to a hospital for assessment by gastroenterology and the general surgeons. Patients with milder infections can be managed in primary care.

Primary Care Treatment
Stop the offending antibiotic. If the patient still requires
treatment for another infection then discuss the options with a Microbiologist if available.

The normal treatment of mild or non-severe CDAD:
PO Metronidazole 500mg TDS for 14 days
If Metronidazole contraindicated: PO Vancomycin 125mg QDS for 14 days

There is no need to test for cure in patients who are
asymptomatic as the test can remain positive for up to 6 weeks after stopping treatment.

Recurrence 
Up to 30% of patients will have a recurrence of their CDAD. Half of these are reacquisition and half are relapse of the original infection. The 1st recurrence should be treated as if it is a new episode with an assessment of severity and either Metronidazole or Vancomycin. Further relapses need more complicated regimens with tapering courses of antibiotics, newer agents such as Fidaxomicin or even consideration for faecal bacteriotherapy, commonly known as a faecal transplant or a human probiotic infusion...yes, really! These recurrent relapses should be treated with the help of a microbiologist and gastroenterologist if available.

Wash–up or RCA!
The final aspect of the management of CDAD is to perform a Root Cause Analysis (RCA) to see if any lessons need to be learnt in order to prevent other patients acquiring C. difficile in the future. This should not be seen as a way of punishing someone for any aspect of the patient’s management but rather as a tool to help learn and inform future practice. It used to be that RCAs for CDAD were only carried out for hospital infections but this is no longer the case, now the Department of Health require RCAs to be completed for all community infections too. Done properly it is a useful tool for improving patient care.

The common avoidable root causes (now known as lapses in care) for why patients get CDAD in primary care might include:
• Failure to implement infection control procedures including hand hygiene for patients with diarrhoea
• Poor cleaning of the environment when a patient has
diarrhoea
• Inappropriate choice, dose or duration of antibiotic to treat
infections
• Recurrent inappropriate courses of antibiotics
 
So hopefully you now agree that the management of Clostridium difficile Associated Disease is pas difficile - “not difficult”. The most important points are:
• Hygiene advice for patients with diarrhoea
• Send a stool sample for C. difficile toxin testing
• Assess for severity of infection
• Stop the predisposing antibiotics
• Start treatment for CDAD
• Perform Root Cause Analysis

Comments are closed.

    RSS Feed

    Facebook has deleted the Microbiology Nuts & Bolts pages - if you want your weekly dose of microbiology then you will need to come here, and we look forward to you continuing to read it!

    Blog Author:

    David Garner
    Consultant Microbiologist
    Surrey, UK

    Please DO NOT advertise products and conferences on our website or blog

    Categories

    All
    Antibiotic Resistance
    Antibiotics
    Basic Concepts
    Clinical Scenarios
    Guidelines
    Infection Control
    In The News
    Microbiology

    Archives

    June 2022
    May 2022
    April 2022
    March 2022
    February 2022
    January 2022
    December 2021
    November 2021
    October 2021
    September 2021
    August 2021
    July 2021
    June 2021
    May 2021
    April 2021
    March 2021
    February 2021
    January 2021
    December 2020
    November 2020
    October 2020
    September 2020
    August 2020
    July 2020
    June 2020
    May 2020
    April 2020
    March 2020
    February 2020
    January 2020
    December 2019
    November 2019
    October 2019
    September 2019
    August 2019
    July 2019
    June 2019
    May 2019
    April 2019
    March 2019
    February 2019
    January 2019
    December 2018
    November 2018
    October 2018
    September 2018
    August 2018
    July 2018
    June 2018
    May 2018
    April 2018
    March 2018
    February 2018
    January 2018
    December 2017
    November 2017
    October 2017
    September 2017
    August 2017
    July 2017
    June 2017
    May 2017
    March 2017
    February 2017
    January 2017
    December 2016
    November 2016
    October 2016
    September 2016
    August 2016
    July 2016
    June 2016
    May 2016
    April 2016
    March 2016
    February 2016
    January 2016
    December 2015
    November 2015
    October 2015
    September 2015
    August 2015
    July 2015
    June 2015
    May 2015
    April 2015
    March 2015
    February 2015
    January 2015
    December 2014
    November 2014
    October 2014
    September 2014
    August 2014
    July 2014
    June 2014
    May 2014
    April 2014
    March 2014
    February 2014
    January 2014
    December 2013
    October 2013
    September 2013
    August 2013
    July 2013

    Categories

    All
    Antibiotic Resistance
    Antibiotics
    Basic Concepts
    Clinical Scenarios
    Guidelines
    Infection Control
    In The News
    Microbiology

    RSS Feed

Powered by Create your own unique website with customizable templates.